Benzinga | Nov 5, 2020 06:09AM EST

Concert Pharmaceuticals Q3 EPS $(0.60) Beats $(0.75) Estimate

Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.75) by 20 percent. This is a 16.67 percent increase over losses of $(0.72) per share from the same period last year.